8 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 5 Not applicable, 3 Phase 2, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Withdrawn 1 |
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Stage IB Non-Small Cell Lung Cancer: new trials by email Literature Review of Stage IB Non-Small Cell Lung Cancer trials Research Report on Stage IB Non-Small Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery Osimertinib, Therapeutic Conventional Surgery - Stage I Non-Small Cell Lung Cancer, Stage IA Non-Small Cell Lung Cancer | Phase 2 | Active not recruiting | University of California, San Francisco | 27 | 2018-07-31 | 2026-03-30 |
| Icotinib for Completed Resected IB NSCLC With EGFR Mutation Icotinib - Lung Neoplasms, Squamous Cell Lung Cancer | Phase 2 | Completed | Sun Yat-sen University | 128 | 2015-01-01 | 2024-09-25 |
| Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer stereotactic radiosurgery, therapeutic conventional surgery, laboratory biomarker analysis - Recurrent Non-small Cell Lung Cancer, Stage IA Non-small Cell Lung Cancer | Not applicable | Withdrawn | University of Southern California | 2014-10-01 | 2015-09-16 | |
| Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients exercise intervention, standard follow-up care, quality-of-life assessment - Extensive Stage Small Cell Lung Cancer, Healthy, no Evidence of Disease | Not applicable | Completed | University of Wisconsin, Madison | 21 | 2013-12-01 | 2019-11-18 |
| Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care educational intervention, medical chart review - Adenocarcinoma of the Lung, Mucinous Adenocarcinoma of the Colon | Not applicable | Completed | Fox Chase Cancer Center | 1440 | 2013-01-01 | 2017-04-06 |
| Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer educational intervention, questionnaire administration, quality-of-life assessment - Stage I Colon Cancer, Stage I Rectal Cancer | Not applicable | Completed | City of Hope Medical Center | 30 | 2013-01-01 | 2013-12-18 |
| Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer acetylsalicylic acid, laboratory biomarker analysis - Adenocarcinoma of the Lung, Recurrent Non-small Cell Lung Cancer | Early Phase 1 | Terminated | Vanderbilt-Ingram Cancer Center | 4 | 2012-10-01 | 2020-01-14 |
| Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer breath test, laboratory biomarker analysis - Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer | Not applicable | Completed | Fox Chase Cancer Center | 41 | 2012-08-23 | 2023-03-13 |
| Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy medical chart review, laboratory biomarker analysis - Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer | Not yet recruiting | National Cancer Institute (NCI) | 950 | 2012-05-01 | 2013-09-20 | |
| Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer questionnaire administration, quality-of-life assessment, counseling intervention - Limited Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | Phase 1 | Completed | Wake Forest University Health Sciences | 6 | 2011-01-01 | 2018-08-01 |
| Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection erlotinib hydrochloride, therapeutic endoscopic surgery, laboratory biomarker analysis - Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 110 | 2004-12-01 | 2013-06-06 |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery gefitinib, placebo, laboratory biomarker analysis - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 3 | Completed | National Cancer Institute (NCI) | 503 | 2002-09-01 | 2015-01-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer paclitaxel, carboplatin, therapeutic conventional surgery - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 3 | Completed | National Cancer Institute (NCI) | 500 | 1996-10-01 | 2013-07-03 |
Carcinoma, Non-Small-Cell Lung (13) · Adenocarcinoma of Lung (5) · Adenocarcinoma, Bronchiolo-Alveolar (2) · Colonic Neoplasms (2) · Rectal Neoplasms (2) · Small Cell Lung Carcinoma (2) · Bronchial Neoplasms (1) · Lung Neoplasms (1) · Tobacco Use Disorder (1)
Carcinoma, Bronchogenic (13) · Lung Diseases (13) · Neoplasms (13) · Neoplasms by Site (13) · Respiratory Tract Diseases (13) · Respiratory Tract Neoplasms (13) · Thoracic Neoplasms (13) · Bronchial Neoplasms (12) · Lung Neoplasms (12) · Adenocarcinoma (5) · Carcinoma (5) · Neoplasms by Histologic Type (5) · Neoplasms, Glandular and Epithelial (5) · Colonic Diseases (2) · Colorectal Neoplasms (2)
Early Intervention, Educational (3) · Methods (3) · Aspirin (1) · Carboplatin (1) · Counseling (1) · Erlotinib Hydrochloride (1) · Gefitinib (1) · Nicotine Replacement Therapy (1) · Paclitaxel (1) · Radiosurgery (1) · Taxes (1) · icotinib (1) · osimertinib (1)
National Cancer Institute (NCI) (4) · Fox Chase Cancer Center (2) · City of Hope Medical Center (1) · Sun Yat-sen University (1) · University of California, San Francisco (1) · University of Southern California (1) · University of Wisconsin, Madison (1) · Vanderbilt-Ingram Cancer Center (1) · Wake Forest University Health Sciences (1)
United States (10) · Canada (2) · China (1)
Collin Blakely, MD, PhD (1) · Crystal Denlinger, MD (1) · Eugene Chung (1) · Gary Strauss (1) · Glennwood Goss (1) · Hossein Borghaei (1) · Kathryn Weaver (1) · Leora Horn (1) · Lesley Seymour (1) · Si-Yu Wang, MD (1) · Steven Keller (1) · Toby Campbell (1) · Virginia Sun (1)
P30CA006927 (1), P30CA014089 (1), P30CA014520 (1), P50CA090949 (1), U10CA021115 (1), U10CA031946 (1)